Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 135.33 | 91.42 | 1.4740 | 1.5136 |
| BT-20 | Erlotinib | 10 | uM | 8 | 156.25 | 28.44 | 109.67 | 91.42 | 1.1625 | 1.0971 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 28.44 | 211.33 | 91.42 | 2.3368 | 2.3374 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 262.33 | 218.75 | 1.1998 | 1.5720 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 312.50 | 129.17 | 218.00 | 218.75 | 1.0183 | 1.1655 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 359.67 | 218.75 | 1.6512 | 3.0659 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 312.50 | 129.17 | 368.67 | 218.75 | 1.6896 | 3.2149 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 258.00 | 218.75 | 1.1851 | 1.5582 |
| BT-20 | Erlotinib | 1 | uM | 8 | 312.50 | 129.17 | 273.67 | 218.75 | 1.2663 | 1.8683 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 304.00 | 218.75 | 1.3657 | 2.0146 |
| BT-20 | Erlotinib | 10 | uM | 8 | 312.50 | 129.17 | 237.67 | 218.75 | 1.0794 | 1.1884 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 332.67 | 218.75 | 1.5449 | 2.9558 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 674.33 | 607.33 | 1.1085 | 1.1810 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 625.00 | 270.83 | 658.67 | 607.33 | 1.0933 | 1.1745 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 855.33 | 607.33 | 1.4049 | 1.6719 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 625.00 | 270.83 | 806.67 | 607.33 | 1.3350 | 1.5799 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 702.33 | 607.33 | 1.1568 | 1.2642 |
| BT-20 | Erlotinib | 1 | uM | 8 | 625.00 | 270.83 | 714.00 | 607.33 | 1.1721 | 1.2837 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 670.67 | 607.33 | 1.1014 | 1.1659 |
| BT-20 | Erlotinib | 10 | uM | 8 | 625.00 | 270.83 | 553.00 | 607.33 | 0.9104 | 0.8433 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 270.83 | 636.33 | 607.33 | 1.0526 | 1.0979 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1672.33 | 1527.17 | 1.0892 | 1.1265 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1685.67 | 1527.17 | 1.1260 | 1.2311 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1830.00 | 1527.17 | 1.2039 | 1.3218 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1848.67 | 1527.17 | 1.2211 | 1.3600 |